Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Federal Reserve presses ahead with quarter-point rate rise despite banking turmoil
    • ‘Close to thin ice’: looming credit crunch puts pressure on Fed
    • Rahul Gandhi sentenced to two years in prison over Modi remarks
    • ‘Master of clocks’: can Macron wait out a crisis of his own making?
    • Germany risks running out of gas next winter, regulator warns
  • UK
    Sections
    • UK Home
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • Bank of England raises interest rates to 4.25% despite banking turmoil
    • Rishi Sunak paid more than £400,000 in tax last year
    • UK inflation jump and banking tumult complicate Bank of England rate decision
    • Red Wall mayor accused of ‘conflict of interest’ over property assets
    • DUP secretly warned against Northern Ireland trade deal demand, letter reveals
  • Companies
    Sections
    • Companies Home
    • Banks in turmoil
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Swiss regulator defends $17bn wipeout of AT1 bonds in Credit Suisse deal
    • US bondholders prepare to sue Swiss government over $17bn Credit Suisse wipeout
    • Accenture to axe 19,000 jobs
    • Hindenburg Research shorts Jack Dorsey’s payments group Block
    • EY’s US boss warns it is ‘premature’ to say whether break-up plan can be salvaged
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Swiss regulator defends $17bn wipeout of AT1 bonds in Credit Suisse deal
    • Live news: Banks shift to Fed’s new lending facility as sector remains under stress
    • US bondholders prepare to sue Swiss government over $17bn Credit Suisse wipeout
    • Hindenburg Research shorts Jack Dorsey’s payments group Block
    • Commercial property risks rise up bank investors’ worry list
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Beware the ‘sensible’ crypto crowd — they’re worse than the fanatics
    • Risk of ‘industrial capture’ looms over AI revolution
    • A hefty shock awaits those who see little difference between Starmer and Sunak
    • EY, KPMG and the fallout of two accounting scandals
    • Credit Suisse’s fate casts a shadow over the European banking sector
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Culture clash: the challenge of uniting fierce rivals UBS and Credit Suisse
    • From SVB to the BBC: why did no one see the crisis coming?
    • Football’s first female super-agent Rafaela Pimenta on dealmaking and discrimination
    • Social media content moderators lead charge for better rights
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Everything I, an Italian, thought I knew about Italian food is wrong
    • We should regulate SUVs out of existence
    • Credit Suisse ‘merch’ and the rush to buy history
    • The bleak beauty of Death Valley
    • My life’s journey through the restaurants of Little Italy
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Johnson & Johnson Co Inc

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Tuesday, 7 February, 2023
    FT News Briefing podcast9 min listen
    The jig is up for the Texas two-step

    UK to design ‘digital pound’ that could fend off a future private tech rival

  • Monday, 6 February, 2023
    News in-depthBankruptcy
    Talc ruling a blow to J&J and the ‘Texas two-step’ bankruptcy jig

    Ruling by US court will make companies think twice about using Chapter 11 schemes to handle lawsuits

  • Tuesday, 31 January, 2023
    Lex
    J&J: court stops the music for the ‘Texas two-step’ Premium content

    Congress may eventually have to step in and create a new club to resolve mass torts

  • Monday, 30 January, 2023
    J&J blocked from using bankruptcy to resolve talcum powder lawsuits

    Ruling from US appeals court casts doubt on future of contentious ‘Texas two-step’ manoeuvre

  • Thursday, 5 January, 2023
    Lex
    J&J/Kenvue: IPO will test investor appetite Premium content

    A successful listing would focus J&J on its pharmaceutical and medical-device business

  • Tuesday, 1 November, 2022
    Lex
    J&J/Abiomed: healthcare giant pays high price to bulk up on medtech Premium content

    EV/ebitda multiple is rich, given the healthcare giant expects any potential cost savings to be ‘very modest’

  • Tuesday, 1 November, 2022
    Johnson & Johnson bucks global M&A slowdown with $16.6bn Abiomed deal

    Purchase of heart pumpmaker to help US pharma group focus on drugs and medical devices

  • Tuesday, 25 October, 2022
    The Big Read
    ‘Texas two-step’: the US legal move letting corporations off the hook

    Critics say the controversial legal manoeuvre allows companies to bypass their responsibilities. But judges are beginning to crack down

  • Monday, 22 August, 2022
    J&J tries to extend its ‘Texas two-step’ to halt two states’ talc cases

    New Mexico and Mississippi say consumer company’s strategy is making a ‘mockery’ of bankruptcy law

  • Tuesday, 19 July, 2022
    J&J blames US dollar strength for second outlook cut in as many quarters

    Pharmaceutical group issues downbeat forecast despite better than expected quarterly results

  • Tuesday, 21 June, 2022
    Behind the Money podcast28 min listen
    Inside Johnson & Johnson’s bankruptcy two-step

    This legal manoeuvre is setting a new precedent for corporations to evade accountability in America

  • Sunday, 6 March, 2022
    J&J targets Chinese biotech deals as western pharma groups look east

    US drugmaker seeks more tie-ups after existing collaboration yields new cancer treatment

  • Tuesday, 1 March, 2022
    LexBankruptcy
    US bankruptcy/J&J: new turn for Texas two-step Premium content

    Ruling opens a fresh chapter for resolving US tort cases

  • Monday, 28 February, 2022
    Health
    US lawmakers plan bill to outlaw ‘Texas two-step’ bankruptcy ploy

    Fight moves to Congress after judge allows J&J to use scheme to help it settle billions in legal claims

  • Friday, 25 February, 2022
    Johnson & Johnson can proceed with controversial bankruptcy strategy, judge rules

    Decision allows group to use the manoeuvre to manage tens of thousands of claims that its baby talc caused cancer

  • Monday, 14 February, 2022
    Legal services
    Architects of ‘Texas two-step’ lambast J&J for its use of the manoeuvre

    Lawyer who drafted statute says companies should not deploy it to ‘skirt’ their obligations

  • Thursday, 6 January, 2022
    Covid-19 vaccines
    Covid vaccine makers face investor pressure over global access

    Asset managers call for pharma executive pay to be linked to equitable distribution of jabs

  • Thursday, 30 December, 2021
    Covid-19 vaccines
    Johnson & Johnson booster slashes risk of Omicron hospitalisation, study shows

    Two doses cut likelihood by up to 85%, according to real-world South African research

  • Sunday, 12 December, 2021
    South Africa
    South Africa’s leader Cyril Ramaphosa tests positive for Covid

    Country tackles one of the first waves of infections caused by Omicron variant

  • Wednesday, 1 December, 2021
    ExplainerCovid-19 vaccines
    Will Covid vaccines have to be updated for Omicron?

    Drugmakers are stress-testing existing jabs while preparing new formulas

  • Monday, 29 November, 2021
    FT live news
    News updates from November 29: WHO warns of ‘very high’ risk from Omicron, Dorsey resigns as Twitter CEO, German inflation hits 6%
  • Friday, 19 November, 2021
    News in-depth
    Johnson & Johnson touts ‘golden moment’ to pursue pharma-led future

    Plan to spin off consumer division has failed to thrill investors

  • Monday, 15 November, 2021
    The FT ViewThe editorial board
    Conglomerates’ cycle of break-ups turns again

    Advisers benefit from multinationals’ current wave of spin-offs

  • Friday, 12 November, 2021
    Lex
    Johnson & Johnson: the break-up band-aid comes off Premium content

    A successful split of the consumer and pharma divisions would, on paper, unlock value

  • Friday, 12 November, 2021
    Johnson & Johnson to spin off consumer business

    World’s largest healthcare group follows trend to slim down with plans to focus on pharmaceuticals

Previous page You are on page 1 Next page

Be part of FT Community

Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

FT Live
US Pharma and Biotech Summit
Leading Life Sciences into the Future
Tuesday, 16th MayNew York, US & Online
Learn more about FT Community

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Banks in turmoil
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In